Alendronate for the treatment of osteoporosis in men

Calcified Tissue International

Volumn 69, Issue 4, 2001, Pages 239-241

  Adami, S ^a   Prizzi, R ^a   Colapietro, F ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Alendronate; Bisphosphonates; Male osteoporosis

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; BISPHOSPHONIC ACID DERIVATIVE; ETIDRONIC ACID; RISEDRONIC ACID;

BONE DENSITY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; DRUG EFFICACY; FRACTURE; HUMAN; MALE; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE;

ALENDRONATE; BONE DENSITY; CLIMACTERIC; FEMALE; FRACTURES, SPONTANEOUS; HUMANS; LUMBAR VERTEBRAE; MALE; META-ANALYSIS; OSTEOPOROSIS, POSTMENOPAUSAL; RANDOMIZED CONTROLLED TRIALS; SEX FACTORS; SPINAL FRACTURES; TREATMENT OUTCOME;

EID: 0034766297     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-001-1066-2     Document Type: Conference Paper

References (19)

1. Bone density fracture risk in men
2. Hip fractures in the elderly: A world-wide projection
3. Osteoporosis in men
4. Bone density variations and their effects on risk of vertebral deformity in men and women studied in thirteen European centers: The EVOS study
5. Assessing bone density in men
6. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen
7. Alendronate for the treatment of osteoporosis in men
8. Alendronate treatment of established primary osteoporosis in men: Two-year results of a prospective comparative two-arm study
9. Prevention of corticosteroid-induced osteoporosis with alendronate in sarcoid patients
10. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis
11. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporois
12. Risedronate therapy prevents corticosteroid-induced bone loss
13. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: A randomized trial
14. Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy
15. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids
16. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
17. Effects of alendronate on bone density in men with primary and secondary osteoporosis
18. Randomised trial (Fracture Intervention Trial, F.I.T.) of effect of alendronate on risk of fracture in women with existing vertebral fractures
19. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures